Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Conference Paper
  • Published:

Biology and application of alphaviruses in gene therapy

Gene Therapy volume 12, pages S92–S97 (2005)Cite this article

Abstract

The broad host cell range and high expression levels of transgenes are features that have made alphaviruses attractive for gene expression studies and gene therapy applications. Particularly, Semliki Forest virus vectors have been applied for large-scale production of recombinant membrane proteins for drug screening purposes and structural biology studies. The high preference of expression in neuronal cells has led to many applications of alphavirus vectors in neuroscience. Studies on localization and transport of recombinant proteins as well as electrophysiological recording have become feasible in primary cultures of neurons and hippocampal slice cultures. Alphaviruses have frequently been used as vaccine vectors for expression of antigens against viruses and tumors. Administration of recombinant viral particles, DNA plasmids or in vitro transcribed RNA has resulted in protection against challenges against lethal viruses and tumors in rodent and primate models. Intratumoral injections of alphavirus vectors expressing reporter and immunostimulatory genes have led to significant tumor regression in mouse models. Modifications of the viral envelope structure have generated targeted Sindbis virus vectors. Astonishingly, conventional Sindbis vectors have demonstrated tumor-specific targeting in animal models due to the high density of laminin receptors on cancer cells. Moreover, encaspulation of Semliki Forest virus vectors in liposomes has provided a means of achieving tumor targeting and protection against the host immune response. Much attention has also been given to the engineering of novel mutant alphavirus vectors with properties such as reduced cytotoxicity, prolonged duration of transgene expression and improved survival of host cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Strauss JH, Strauss EG . The alphaviruses: gene expression, replication, and evolution. Microbiol Rev 1994; 58: 491–562.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Mathiot CC et al. An outbreak of human Semliki Forest virus infections in Central African Republic. Am J Trop Med Hyg 1990; 4: 386–393.

    Article  Google Scholar 

  3. Liljeström P, Garoff H . A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/Technology 1991; 9: 1356–1361.

    Article  Google Scholar 

  4. Xiong C et al. Sindbis virus: an efficient, broad host range vector for gene expression in animal cells. Science 1989; 243: 1189–1191.

    Article  Google Scholar 

  5. Davis NL, Brown KW, Johnston RE . In vitro synthesis of infectious Venezuelan equine encephalitis virus RNA from a cDNA clone: Analysis of a viable deletion mutant. Virology 1989; 171: 189–204.

    Article  CAS  PubMed  Google Scholar 

  6. DiCiommo DP, Bremner R . Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J Biol Chem 1998; 273: 18060–18066.

    Article  CAS  PubMed  Google Scholar 

  7. Lundstrom K . Semliki Forest virus vectors for rapid and high-level expression of integral membrane proteins. Biochim Biophys Acta 2003; 1610: 90–96.

    Article  CAS  PubMed  Google Scholar 

  8. Lundstrom K et al. Semliki Forest virus vectors: efficient vehicles for in vitro and in vivo gene delivery. FEBS Lett 2001; 504: 99–103.

    Article  CAS  PubMed  Google Scholar 

  9. Blasey HD et al. Large scale transient 5-HT3 reecptor production with the Semliki Forest virus system. Cytotechnology 2000; 32: 199–208.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lundstrom K . Structural genomics on membrane proteins: the MePNet approach. Curr Opin Drug Discov Devel 2004; 7: 342–346.

    CAS  PubMed  Google Scholar 

  11. Olkkonen VM et al. Expression of heterologous proteins in cultured rat hippocampal neurons using the Semliki Forest virus vector. J Neurosci Res 1993; 35: 445–451.

    Article  CAS  PubMed  Google Scholar 

  12. Ehrengruber MU et al. Recombinant Semliki Forest virus and Sindbis virus efficiently infect neurons in hippocampal slice cultures. Proc Natl Acad Sci USA 1999; 96: 7041–7046.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ehrengruber MU et al. Gene transfer into neurons from hippocampal slices: comparison of recombinant Semliki Forest Virus, adenovirus, adeno-associated virus, lentivirus, and measles virus. Mol Cell Neurosci 2001; 17: 855–871.

    Article  CAS  PubMed  Google Scholar 

  14. Hennou S et al. Homer-1a/Vesl-1S enhances hippocampal synaptic transmission. Eur J Neurosci 2003; 18: 811–819.

    Article  PubMed  Google Scholar 

  15. Altman-Hamamdzic S et al. Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system. Gene Therapy 1997; 4: 815–822.

    Article  CAS  PubMed  Google Scholar 

  16. Lundstrom K, Richards JG, Pink JR, Jenck F . Efficient in vivo expression of a reporter gene in rat brain after injection of recombinant replication-deficient Semliki Forets virus. Gene Ther Mol Biol 1999; 3: 15–23.

    Google Scholar 

  17. Hardy PA et al. Recombinant Semliki forest virus infects and kills human prostate cancer cell lines and prostatic duct epithelial cells ex vivo. Int J Mol Med 2000; 5: 241–245.

    CAS  PubMed  Google Scholar 

  18. Loimas S et al. Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy. Cancer Gene Ther 2001; 8: 137–144.

    Article  CAS  PubMed  Google Scholar 

  19. Lundstrom K . Alphavirus vectors for vaccine production and gene therapy. Expert Rev Vaccines 2003; 2: 447–459.

    Article  CAS  PubMed  Google Scholar 

  20. Ying H et al. Cancer therapy using a self-replicating RNA vaccine. Nat Med 1999; 5: 823–827.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Leitner WW et al. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 2003; 9: 33–39.

    Article  CAS  PubMed  Google Scholar 

  22. Velders MP et al. Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16 E7 RNA. Cancer Res 2001; 61: 7861–7867.

    CAS  PubMed  Google Scholar 

  23. Asselin-Paturel C et al. Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography. Gene Therapy 1999; 6: 606–615.

    Article  CAS  PubMed  Google Scholar 

  24. Murphy AM, Morris-Downes MM, Sheahan BJ, Atkins GJ . Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles. Gene Therapy 2000; 7: 1477–1482.

    Article  CAS  PubMed  Google Scholar 

  25. Murphy AM, Sheahan BJ, Atkins GJ . Induction of apoptosis in BCL-2-expressing rat prostate cancer cells using the Semliki Forest virus vector. Int J Cancer 2001; 94: 572–578.

    Article  CAS  PubMed  Google Scholar 

  26. Ohno K et al. Cell-specific targeting of Sindbis virus vectors displaying IgG binding domains of protein A. Nat Biotechnol 1997; 15: 763–767.

    Article  CAS  PubMed  Google Scholar 

  27. Tseng JC et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 2004; 22: 70–77.

    Article  CAS  PubMed  Google Scholar 

  28. Lundstrom K, Boulikas T . Viral and non-viral vectors in gene therapy: technology development and clinical trials. Technol Cancer Res Treatment 2003; 2: 471–486.

    Article  CAS  Google Scholar 

  29. Ren H et al. Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene—a phase I/II clinical protocol. J Neurooncol 2003; 64: 147–154.

    CAS  PubMed  Google Scholar 

  30. Agapov EV et al. Non-cytopathogenic Sindbis RNA vectors for heterologous gene expression. Proc Natl Acad Sci USA 1998; 95: 12989–12994.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Boorsma M et al. A temperature-regulated replicon-based DNA expression system. Nat Biotechnol 2000; 18: 429–432.

    Article  CAS  PubMed  Google Scholar 

  32. Lundstrom K, Abenavoli A, Malgaroli A, Ehrengruber MU . Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitive for long-term enhancement of transgene expression. Mol Ther 2003; 7: 202–209.

    Article  CAS  PubMed  Google Scholar 

  33. Ehrengruber MU et al. Semliki Forest virus A7(74) transduces hippocampal neurons and glial cells in a temperature-dependent dual manner. J Neurovirol 2003; 9: 16–28.

    Article  CAS  PubMed  Google Scholar 

  34. Kim J et al. Sindbis vector SINrep(nsP2S726): a tool for rapid heterologous expression with attenuated cytotoxicity in neurons. J Neurosci Methods 2004; 133: 81–90.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Regulon Inc./BioXtal, Epalinges, Switzerland

    K Lundstrom

Authors
  1. K Lundstrom
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lundstrom, K. Biology and application of alphaviruses in gene therapy. Gene Ther 12 (Suppl 1), S92–S97 (2005). https://doi.org/10.1038/sj.gt.3302620

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302620

Keywords

This article is cited by

Search

Advanced search

Quick links